Featured Research

from universities, journals, and other organizations

Antibody Therapy Reduces Asthma In Mice

Date:
March 6, 2006
Source:
Journal of Clinical Investigation
Summary:
Asthma rates are rapidly increasing, particularly in children. Although asthma is mediated in part by activation of special immune cells called Th2 cells, the precise causes are unclear. Now scientists report that a small allergy-inducing protein called C5a produced in the lungs can prevent or induce asthma, depending upon the timing of allergen exposure.

Asthma rates are rapidly increasing, particularly in children. Although asthma is mediated in part by activation of special immune cells called Th2 cells, the precise causes are unclear.

Now, in a study appearing in the March issue of the Journal of Clinical Investigation, Jörg Köhl and colleagues from the Cincinnati Children's Hospital Research Foundation report that a small allergy-inducing protein called C5a produced in the lungs can prevent or induce asthma, depending upon the timing of allergen exposure.

The authors blocked the C5a receptor (C5aR) by either giving normal mice an antibody against C5aR, or by genetically deleting C5aR. The researchers then determined the animals' response to inhalation of one of two allergens: egg ovalbumin (OVA), which fails to induce asthma; or house dust mites, which induce asthma-like symptoms relevant to human disease.

The authors found that mice in which C5aR was blocked or deleted prior to exposure to either allergen developed asthma-like symptoms such as a strong Th2 cell response, mucus production, and airway inflammation. To identify the mechanism by which C5aR signaling prevents this response, the researchers looked at immune cells called dendritic cells (DCs) in the mouse lungs. C5aR blockade was found to directly increase the ratio of pro-asthma "mDCs" to anti-asthma "pDCs" leading to Th2 sensitization, in the absence of allergen, but even more so following allergen exposure, demonstrating that C5aR prevents cell activation and recruitment.

Paradoxically, when C5aR was blocked after allergen exposure, the allergic response was dramatically prevented, and the severity of asthma-like symptoms was reduced, suggesting that C5aR increases the body's response to asthma-inducing stimuli only in an established allergic environment.

In an accompanying commentary, Bart N. Lambrecht from Erasmus University Medical Center in The Netherlands states that these studies "show that C5aR blockade promotes Th2 sensitization upon first exposure to inhaled allergen, whereas C5aR blockade during established inflammation suppresses the cardinal features of asthma."


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kohl et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. Journal of Clinical Investigation, 2006; 116 (3): 783 DOI: 10.1172/JCI26582

Cite This Page:

Journal of Clinical Investigation. "Antibody Therapy Reduces Asthma In Mice." ScienceDaily. ScienceDaily, 6 March 2006. <www.sciencedaily.com/releases/2006/03/060306091153.htm>.
Journal of Clinical Investigation. (2006, March 6). Antibody Therapy Reduces Asthma In Mice. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2006/03/060306091153.htm
Journal of Clinical Investigation. "Antibody Therapy Reduces Asthma In Mice." ScienceDaily. www.sciencedaily.com/releases/2006/03/060306091153.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) — Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) — Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) — Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) — A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins